Aggleton JP, Albasser MM, Aggleton DJ, Poirier GL, Pearce JM (2010) Lesions of the rat perirhinal cortex spare the acquisition of a complex configural visual discrimination yet impair object recognition. Behav Neurosci 124:55
Article PubMed PubMed Central Google Scholar
Agrawal R, Tyagi E, Shukla R, Nath C (2011) Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur Neuropsychopharmacol 21:261–273
Article CAS PubMed Google Scholar
Aillaud I, Funke SA (2022) Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease. Cell Mol Neurobiol
Akanuma S, Ohtsuki S, Doi Y, Tachikawa M, Ito S, Hori S, Asashima T, Hashimoto T, Yamada K, Ueda K, Iwatsubo T, Terasaki T (2008) ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1–40) at the blood-brain barrier. Neurochem Int 52:956–961
Article CAS PubMed Google Scholar
Alley GM, Bailey JA, Chen D, Ray B, Puli LK, Tanila H, Banerjee PK, Lahiri DK (2010) Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. J Neurosci Res 88:143–154
Article CAS PubMed PubMed Central Google Scholar
Alwaili K, Bailey D, Awan Z, Bailey SD, Ruel I, Hafiane A, Krimbou L, Laboissiere S, Genest J (2012) The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta 1821:405–415
Article CAS PubMed Google Scholar
Alzheimer’s Association (2023) 2023 Alzheimer’s disease facts and figures. Alzheimers Dement 19:1598–1695
Amram S, Iram T, Lazdon E, Vassar R, Ben-Porath I, Frenkel D (2019) Astrocyte senescence in an Alzheimer’s disease mouse model is mediated by TGF-β1 and results in neurotoxicity. BioRxiv:700013
Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93–110
Article CAS PubMed Google Scholar
Ayieng’a EO, Afify EA, Abuiessa SA, Elblehi SS, El-Gowilly SM, El-Mas MM (2023) Morphine aggravates inflammatory, behavioral, and hippocampal structural deficits in septic rats. Sci Rep 13:21460
Article CAS PubMed PubMed Central Google Scholar
Bae JJ, Xiang YY, Martinez-Canabal A, Frankland PW, Yang BB, Lu WY (2011) Increased transforming growth factor-β1 modulates glutamate receptor expression in the hippocampus. Int J Physiol Pathophysiol Pharmacol 3:9–20
Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, Maruff P (2017) Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimers Dement (Amst) 6:108–121
Baldwin KT, Eroglu C (2017) Molecular mechanisms of astrocyte-induced synaptogenesis. Curr Opin Neurobiol 45:113–120
Article CAS PubMed PubMed Central Google Scholar
Bao J, Mahaman YAR, Liu R, Wang JZ, Zhang Z, Zhang B, Wang X (2017) Sex Differences in the Cognitive and Hippocampal Effects of Streptozotocin in an Animal Model of Sporadic AD. Front Aging Neurosci 9:347
Article PubMed PubMed Central Google Scholar
Botton PH, Costa MS, Ardais AP, Mioranzza S, Souza DO, da Rocha JBT, Porciúncula LO (2010) Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice. Behav Brain Res 214:254–259
Article CAS PubMed Google Scholar
Boucher P, Li WP, Matz RL, Takayama Y, Auwerx J, Anderson RG, Herz J (2007) LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS ONE 2:e448
Article PubMed PubMed Central Google Scholar
Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M, Chang L, Yan LJ, Zhao B (2016) Role of RAGE in Alzheimer’s Disease. Cell Mol Neurobiol 36:483–495
Article CAS PubMed Google Scholar
Chan SL, Kim WS, Kwok JB, Hill AF, Cappai R, Rye KA, Garner B (2008) ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem 106:793–804
Article CAS PubMed Google Scholar
Cibičková L (2011) Statins and their influence on brain cholesterol. J Clin Lipidol 5:373–379
Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Academic, New York, NY
Cornejo F, von Bernhardi R (2016) Age-Dependent Changes in the Activation and Regulation of Microglia. Adv Exp Med Biol 949:205–226
Article CAS PubMed Google Scholar
Corona AW, Kodoma N, Casali BT, Landreth GE (2016) ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice. J Neuroimmune Pharmacol 11:61–72
Cruz JNd, Magro DDD, Lima DDd C, JGPd (2017) Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N-methyl-D-aspartate receptor in anxiety: a literature review. Brazilian J Pharm Sci 53:e16102
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
Dias CP, De Lima MNM, Presti-Torres J, Dornelles A, Garcia VA, Scalco FS, Guimarães MR, Constantino L, Budni P, Dal-Pizzol F (2007) Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neuroscience 146:1719–1725
Die J, Wang K, Fan L, Jiang Y, Shi Z (2010) Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions. Brain Res 1346:251–261
Article CAS PubMed Google Scholar
Dietschy JM, Turley SD (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375–1397
Article CAS PubMed Google Scholar
Dou KX, Tan MS, Tan CC, Cao XP, Hou XH, Guo QH, Tan L, Mok V, Yu JT (2018) Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials. Alzheimers Res Ther 10:126
Article PubMed PubMed Central Google Scholar
Dubey H, Gulati K, Ray A (2018a) Recent studies on cellular and molecular mechanisms in Alzheimer’s disease: focus on epigenetic factors and histone deacetylase. Rev Neurosci 29:241–260
Article CAS PubMed Google Scholar
Dubey H, Gulati K, Ray A (2018b) Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer’s disease in rats. Neurotoxicology 66:58–65
Article CAS PubMed Google Scholar
El-Mezayen NS, Abd El Moneim RA, El-Rewini SH (2022) Vitamin B12 as a cholinergic system modulator and blood brain barrier integrity restorer in Alzheimer’s disease. Eur J Pharm Sci 174:106201
Article CAS PubMed Google Scholar
El-Sayyad SM, Ali MA, Kandil LS, Ragab GM, Abdelhamid Ibrahim SS (2021) Metformin and omega-3 fish oil elicit anti-inflammatory effects via modulation of some dysregulated micro RNAs expression and signaling pathways in experimental induced arthritis. Int Immunopharmacol 92:107362
Article CAS PubMed Google Scholar
El Asmar Z, Terrand J, Jenty M, Host L, Mlih M, Zerr A, Justiniano H, Matz RL, Boudier C, Scholler E, Garnier JM, Bertaccini D, Thiersé D, Schaeffer C, Van Dorsselaer A, Herz J, Bruban V, Boucher P (2016) Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation. J Biol Chem 291:5116–5127
Article PubMed PubMed Central Google Scholar
Elali A, Rivest S (2013) The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer’s disease. Front Physiol 4:45
Comments (0)